Skip to main content
The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Quality & Risk
Supply Chain
German drug manufacturers face biggest hit from US supply chain bill: GlobalData
Germany is at the greatest commercial risk from Washington’s onshoring policies that may trigger tariff and non-tariff measures, warns the data and analytics firm.
Aug. 18, 2026
Supply Chain
FDA’s GDUFA IV commitment letter supports onshoring of generic drug manufacturing
Aug. 13, 2026
Quality & Risk
Catalent taps AI to change quality management in pharma manufacturing
Aug. 12, 2026
Supply Chain
Department of Commerce funds biomanufacturing, pharma manufacturing hubs
July 22, 2026
Supply Chain
Senators sponsor bill seeking transparency on foreign control in US drug supply chain
July 17, 2026
Supply Chain
FDA proposed rule eases drug manufacturing registration, boosts foreign source visibility
July 13, 2026
Supply Chain
US biotech leadership at risk as China dominates manufacturing: survey
June 23, 2026
Supply Chain
DoD’s labeling of WuXi AppTec as a Chinese military company causes ‘irreparable’ harm
June 18, 2026
Supply Chain
India’s CRDMOs stand to gain from addition of China’s WuXi AppTec to Pentagon list
June 15, 2026
Looking for Something?
Load More Content
